Author

Alexa Halliday

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alejandra G. SerranoiD· 2 shared Bingnan ZhangiD· 2 shared Carl Michael GayiD· 2 shared Catherine Allison StewartiD· 2 shared John Victor HeymachiD· 2 shared Kavya RamkumariD· 2 shared Lauren A. ByersiD· 2 shared Loukia Georgiou KaracostaiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alejandra G. SerranoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

DLL3 expression predicts response and long-term outcome in small cell lung cancer patients treated with tarlatamab

Bingnan Zhang, Lingzhi Hong, Kaiwen Wang, Catherine Allison Stewart, Komal Shah, Wei-lien Wang, Alejandra Serrano, Luisa Maren Solis Soto, Robert J. Cardnell, Alexa Halliday, Mitchell Parma, Elyse R. Lopez, Mukulika Bose, Cole Ruoff, Shafqat Ehsan, , Lauren A. Byers

This study shows DLL3 expression level predicts response and long-term survival in SCLC patients treated with tarlatamab.

bioRxiv · Sep 7, 2026 · PreprintCancer Biology

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

Catherine Allison Stewart, Kavya Ramkumar, Runsheng Wang, Yuanxin Xi, Alexa Halliday, Lixia Diao, Qi Wang, Alejandra G. Serrano, Sarah Groves, Simon Heeke, Azusa Tanimoto, Laura Kaiser, Yan Yang, Whitney E. Lewis, Jody V. Vykoukal, , Carl Michael Gay

This study identifies YAP1-positive cells in relapsed SCLC that exhibit drug tolerance and transition from SCLC to LCNEC-like features, losing some targets but gaining others.

Journal of Thoracic Oncology · Apr 20, 2026Peer-reviewedCancer Biology